XYTOS uses the following diagnostics techniques before, during and after the treatment to determine success. In addition, the patient can follow up with their personal physicians and use all the standard testing to determine that the XYTOS treatment process was successful. The diagnostic tests performed by XYTOS are: darkfield microscopy, sonography, and fluoroscopy.

Darkfield Microscopy

It is relatively easy for the treating doctor to determine the change in the patients cell structure from high valence cells (that indicate a cancerous disturbance) to healthy cells using Darkfield Microscopy along with the XYTOS charts showing the changes in cell structure, The XYTOS medical staff uses Darkfield Microscopy before, during and after the treatment process.

The most notable differences in blood cells is the transformation of healthy red blood cells in to what is referred to as high valence cells, which as stated indicate a cancerous disturbance in the cell structure. White cells follow a similar pattern but the differences are harder to detect by the untrained eye so the patients is educated on how to interpret the changes in their red blood cells as the treatment progresses.

A similar pattern also develops with blood substances such as fibrin and crystals but, as stated, to simplify the interpretation of the blood from the patient's point of view the concentration remains on the red blood cells. Note that the change in the patients blood over the 2 to 3 weeks that the patient is being treated at the XYTOS Centre for Advanced Medicine will shows a certain degree of improvement depending entirely on the degree of cancer present. The XYTOS objective is to show that the high valence cells, which as stated indicate a cancerous disturbance are moving back to a healthy state. The full movement of the cells can take a bit longer but the full movement can be confirmed through blood work at the patients primary care Physician our by a follow up at the XYTOS Treatment Centre, if the patients wishes to travel back to the XYTOS Treatment Centre.

The vast majority of patients with a Karnofsky scale of approximately 70+ lie in the area between what is referenced as FUNCTIONAL DISTURBANCE DIVIDE and NEOPLASTIC PRESENCE DIVIDE. This makes it easier for the treating doctors to estimate the cell disturbance. These terms are explained to the patient during the treatment process.

Again the XYTOS goal is to involve the patients in each step of the treatment process so the patient will be able to see their cell structure on the monitors at the XYTOS Treatment Centre before, during and after their treatment process. Again the patient receives a copy of a DVD showing the change in their cell structure during the treatment process along with a explanation on what to look for before, during and after the XYTOS treatments.

Sonography

In addition to Fluorescent Scanning and Darkfield Microscopy, XYTOS also use the Power Color Doppler Sonogram to produce sonographic images of the prostate. The Sonogram uses safe, painless high-frequency sound waves to produce a detailed image of the prostate as well as other internal organs. The high resolution of the Sonogram accompanied with the Color Doppler images allow XYTOS to measure blood flow in the prostate as well as measure the size of a tumor. As a tumor develops it must have blood flow in order to form. In typical cases, altered blood flow can be seen years before the tumor actually develops. Power Color Doppler Sonogram allows the XYTOS medical staff to see observe and measure blood flows that feeds, and always precede, a tumor. The amount of blood flow in the prostate indicates the aggressiveness of a tumor, meaning that areas of increased flow are more likely to contain cancer and a tumor without blood flow is static or diminishing.
The ability of Power Color Doppler Ultrasound (Sonogram) to precisely locate and measure questionable tissue and blood flows allows for a more accurate diagnosis of Prostate Cancer and the procedure can be repeated as often as necessary.
As the XYTOS treatment progresses XYTOS uses the Sonogram along with Fluorescent Scanning and Darkfield Microscopy to give the patient a complete view of the success of the treatment. Again the XYTOS goal is to involve the patients in each step of the treatment process so the patient will be able to see their Sonogram images as they are being recorded on the XYTOS monitors before, during and on completion of the treatment process. Again the patient receives a copy of a DVD showing the change in their prostate during the treatment process along with a explanation on what to look for before, during and after the XYTOS treatment. This information is also made available to the patients Primary Care Physician

Fluorescent Scanning
(Fluoroscopy)

Fluorescent Scanning (Fluoroscopy) is the XYTOS visualization of light emitting compounds concentrated within malignant tissue when activated by external energy such as light and sound.

The Fluorescent Scanning technique used by XYTOS in practice means that XyChloro has light emitting compounds within its structure that attach to the malignant cells beneath the skin or organ surface and can be precisely illuminated. The size location and number of cancerous cells can be picked up by specialized diagnostic lasers and recorded by camera with special filters. This process helps to take the guesswork out of looking for cancerous cells. The illumination is possible because XyChloro was bio-engineered to attach to cancer cells, which have an anaerobic (no oxygen) metabolism and produce lactate. Healthy cells have an aerobic (oxygen) mechanism. XyChloro® is positively charged and can bind to the negatively charged lactate in the cancer cells. Because XyChloro® is positively charged like a patients healthy cells XyChloro® will pass through healthy cells leaving the healthy cells unaffected. XyChloro® will remain in the cancerous cells for several days waiting to be activated by the XYTOS light and sound delivery system. If XyChloro® is not activated it will clear out of the cancerous cells in approximately 3 weeks.

Fluorescent Scanning will soon become the standard diagnostic technique for breast and skin cancer patients for two reasons. The first reason is that the treating doctors can clearly see the cancer they are treating through the florescence of XyChloro®, and there is no guessing as to the location of the cancer cells. Additionally the type of cancer (i.e. hormone or non-hormone respective) is not an issue with the XYTOS treatment process because XyChloro will attach to all forms of cancer cells. Thus the XYTOS treatment procedure will work the same on cancer cells that are hormone or non-hormone respective. Secondly Fluorescent Scanning can detect cancer at the cellular level months or years before any current diagnostic technique such as the mammogram; and of course it is well known that the earliest possible detection in cancer is vital.

In short Fluorescent Scanning will show cancerous cells at the cellular level well before it develops into a lump. This means that the so-called pre-breast cancer "Stage 0" can be illuminated and treated at the earliest possible stage. XYTOS is unaware of any other radiological or diagnostic procedure, which can accomplish this objective.

In practice the patient can view the progress of her breast cancer through Fluorescent Scanning on the monitors in each treatment room. Fluorescent Scanning is done every second or third day during the patient's treatment at the XYTOS Centre for Advanced Medicine. Additionally the patient receives a copy of a DVD showing the pictures of the cancerous cells before, during and after the XYTOS treatments.